FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
Agios Pharma (NASDAQ: AGIO) reported Q1 EPS of ($0.59), $1.08 better than the analyst estimate of ($1.67). Revenue for the quarter came in at $87.1 million versus the consensus estimate of $30.83 million.
Though there is no modern playbook for a crisis like the COVID-19 pandemic, we moved quickly to reduce the risk of our teams... More

